Nanoscope Therapeutics

4:15 PM - 4:30 PM (PDT), Tuesday, June 14, 2022
Clinical Stage Occular Gene Therapy Startup
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Texas
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
MCO-010
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2